Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1967]
News [3164]
Articles [130]
Editorials [3]
Conferences [121]
elearning [17]
Dealing with peripheral neuropathic pain in multiple myeloma
Prof Wolfgang Grisold - Ludwig Boltzmann Gesellschaft, Vienna, Austria
Dealing with peripheral neuropathic pain in multiple myeloma ( Prof Wolfgang Grisold - Ludwig Boltzmann Gesellschaft, Vienna, Austria )
2 May 2018
Mechanisms and prospects of a novel CDK9 inhibitor for DLBCL
Dr Susan Galbraith - AstraZeneca, Cambridge, UK
Mechanisms and prospects of a novel CDK9 inhibitor for DLBCL ( Dr Susan Galbraith - AstraZeneca, Cambridge, UK )
25 Apr 2018
Returns from data sharing in HARMONY
Carin Smand - European Haematology Association (EHA)
Returns from data sharing in HARMONY ( Carin Smand - European Haematology Association (EHA) )
5 Jan 2018
Different perspectives shaping the HARMONY project
Patricia Van Dijck - Novartis
Different perspectives shaping the HARMONY project ( Patricia Van Dijck - Novartis )
5 Jan 2018
The importance of the HARMONY project in Europe
Guillermo Sanz Santillana - Instituto de Investigación Médica Hospital la Fe
The importance of the HARMONY project in Europe ( Guillermo Sanz Santillana - Instituto de Investigación Médica Hospital la Fe )
5 Jan 2018
HARMONY - a bench to bedside process
Pam Bacon - Celgene
HARMONY - a bench to bedside process ( Pam Bacon - Celgene )
5 Jan 2018
HARMONY will have a big impact through inclusion
Dr Egge van de Poel - Erasmus Medical Centre, Rotterdam, Netherlands
HARMONY will have a big impact through inclusion ( Dr Egge van de Poel - Erasmus Medical Centre, Rotterdam, Netherlands )
5 Jan 2018
The patient perspective for HARMONY
Tamas Bereczky - LeukaNet
The patient perspective for HARMONY ( Tamas Bereczky - LeukaNet )
5 Jan 2018
Next generation sequencing identifies smoldering multiple myeloma patients with...
Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression ( Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2017
Venetoclax plus rituximab for patients with relapsed / refractory CLL
Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Venetoclax plus rituximab for patients with relapsed / refractory CLL ( Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2017
Daratumumab for patients with multiple myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Daratumumab for patients with multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
12 Dec 2017
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib...
Prof Meletios Dimopoulos - National and Kapodistrian University of Athens...
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation